ArticleArchives of orthopaedic and trauma surgery2025
The obese patient undergoing reverse shoulder arthroplasty for a fracture has similar postoperative functional outcomes as the non-obese patient, but with a lower range of motion.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe obesity epidemic is especially common among the elderly population. As the majority of patients with proximal humeral fractures undergoing a reverse shoulder arthroplasty (RSA) are elderly, it is essential to understand how obesity can impact the outcomes of shoulder arthroplasty in this patient group. However, there is limited consensus on the functional outcome measures and range of motion in obese patients undergoing RSA for fractures compared to non-obese patients. MATERIALS AND
methodsA retrospective study was conducted, including all patients who underwent RSA surgery for proximal humeral fractures from 2010 to 2022. The patients were divided into two groups based on their body mass index (BMI) at the time of surgery: the obese group (BMI ≥ 30 kg/m
resultsOne hundred thirty one patients comprise the final sample of the study, with 65 in the obesity group and 66 in the control group. There were no significant differences in mean scores on the CM (p = 0.068), UCLA (p = 0.169), and QuickDASH scales (p = 0.064). However, differences were found in adjusted CM (p = 0.046), forward flexion (p = 0.013), abduction (p = 0.011), external rotation (p = 0.047), and internal rotation (p = 0.039). The estimated 14-year survival in the obesity group was 92.2% (95% CI 80.0-100), while in the control group, it was 95.0% (95% CI 90.0-100) (p = 0.680).
conclusionsThe obese patient who underwent treatment with RSA for a proximal humeral fracture has functional outcomes and an estimated 14-year survival comparable to those of non-obese patients. However, postoperative shoulder mobility is significantly worse in obese patients at the 2-year postoperative follow-up. LEVEL OF EVIDENCE: III.
Indexed as
Identifiers
40072618What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.